MDGL - Latest News
Madrigal Pharmaceuticals, Inc. (MDGL), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $11.73B. Beta to the broader market is -1.00.
The article list below shows the most recent MDGL headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent MDGL Headlines
Madrigal's Rezdiffra Hits $1.3B Run Rate as MASH Pipeline Expands
marketbeat.com - Aug 15, 2026
Madrigal Pharmaceuticals NASDAQ: MDGL said Rezdiffra continued to post strong commercial growth in the second quarter of 2026, while the company expan
John Paulson's Top Q2 2026 Move: Exiting Agnico Eagle Mines Ltd at a -5.11% Portfolio Impact
gurufocus.com - Aug 14, 2026
Paulson and Co.
Madrigal Appoints John C. Reed, M.D.
globenewswire.com - Aug 12, 2026
CONSHOHOCKEN, Pa. , Aug.
Madrigal Pharmaceuticals, Inc. (MDGL) Presents at Canaccord Genuity's 46th Annual Growth Conference Transcript
seekingalpha.com - Aug 11, 2026
Madrigal Pharmaceuticals, Inc.
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com - Aug 6, 2026
CONSHOHOCKEN, Pa. , Aug.
How News Affects MDGL Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track MDGL's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked MDGL news questions
- What is the latest MDGL news headline?
- The most recent MDGL headline (Aug 15, 2026) is "Madrigal's Rezdiffra Hits $1.3B Run Rate as MASH Pipeline Expands". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the MDGL news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What MDGL news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual MDGL options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.